ANIP
ANI Pharmaceuticals, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$71.20
−1.09%0
Insider buys (3m)
11
Insider sells (3m)
-$2.2M
Net value (3m)
-12.0%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Sep 1, 2026 | CAREY STEPHEN P. · officer: SVP & CFO | Sale | 2,850 | $73 |
| Aug 27, 2026 | Gosebruch Henry O · director | A-Award | 6,662 | $0.00 |
| Aug 26, 2026 | Lalwani Nikhil · director, officer: PRESIDENT & CEO | Sale | 5,400 | $74 |
| Aug 13, 2026 | Cook Meredith · officer: SR. VP, GENERAL COUNSEL & SEC. | Sale | 500 | $75 |
| Aug 11, 2026 | Gutwerg Ori · officer: SVP, GENERICS | Sale | 3,162 | $77 |
| Jul 30, 2026 | CAREY STEPHEN P. · officer: SVP & CFO | Sale | 2,850 | $81 |
| Jul 21, 2026 | Cook Meredith · officer: SR. VP, GENERAL COUNSEL & SEC. | F-InKind | 2,466 | $79 |
| Jul 14, 2026 | Cook Meredith · officer: SR. VP, GENERAL COUNSEL & SEC. | Sale | 500 | $82 |
| Jul 6, 2026 | CAREY STEPHEN P. · officer: SVP & CFO | M-Exempt | 3,313 | $50 |
| Jul 6, 2026 | CAREY STEPHEN P. · officer: SVP & CFO | Sale | 3,313 | $86 |
| Jun 30, 2026 | CAREY STEPHEN P. · officer: SVP & CFO | Sale | 2,850 | $84 |
| Jun 15, 2026 | Cook Meredith · officer: SR. VP, GENERAL COUNSEL & SEC. | Sale | 500 | $82 |
| Jun 10, 2026 | Pera Antonio R · director | A-Award | 4,357 | $0.00 |
| Jun 10, 2026 | HAUGHEY THOMAS · director | A-Award | 4,357 | $0.00 |
| Jun 10, 2026 | TANNENBAUM RENEE P · director | A-Award | 4,357 | $0.00 |
| Jun 10, 2026 | Leonard Matthew J · director | A-Award | 4,357 | $0.00 |
| Jun 10, 2026 | HAUGHEY THOMAS · director | Sale | 2,000 | $81 |
| Jun 10, 2026 | Thoma Jeanne · director | A-Award | 4,357 | $0.00 |
| Jun 9, 2026 | CAREY STEPHEN P. · officer: SVP & CFO | Sale | 3,312 | $80 |
| Jun 9, 2026 | CAREY STEPHEN P. · officer: SVP & CFO | M-Exempt | 3,312 | $50 |
| May 13, 2026 | Walsh Patrick D · director | Sale | 3,973 | $81 |
| May 13, 2026 | Rowland Thomas Andrew · officer: SVP, HEAD - ESTABLISHED BRANDS | Sale | 459 | $79 |
| May 13, 2026 | Walsh Patrick D · director | Sale | 10,000 | $81 |
| May 13, 2026 | Gutwerg Ori · officer: SVP, GENERICS | Sale | 2,772 | $80 |
| May 13, 2026 | Cook Meredith · officer: SR. VP, GENERAL COUNSEL & SEC. | Sale | 500 | $78 |
| May 13, 2026 | Lalwani Nikhil · director, officer: PRESIDENT & CEO | Sale | 55,000 | $78 |
| Apr 13, 2026 | Cook Meredith · officer: SR. VP, GENERAL COUNSEL & SEC. | Sale | 500 | $78 |
| Mar 13, 2026 | Rowland Thomas Andrew · officer: SVP, HEAD - ESTABLISHED BRANDS | Sale | 4,772 | $75 |
| Mar 13, 2026 | Mutz Christopher · officer: HEAD OF RARE DISEASE | Sale | 3,162 | $72 |
| Mar 13, 2026 | Cook Meredith · officer: SR. VP, GENERAL COUNSEL & SEC. | Sale | 500 | $73 |
Institutional positioning
13F filings over the trailing two quarters
New 96Increased 232Reduced 177Sold out 24
| Filer | Action | Shares | Filed |
|---|---|---|---|
| BlackRock, Inc. | Increased | 2,958,646 | Aug 7, 2026 |
| BLACKROCK, INC. | Increased | 2,747,492 | May 13, 2026 |
| Soleus Capital Management, L.P. | Increased | 867,760 | Aug 11, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Increased | 838,224 | Aug 13, 2026 |
| STATE STREET CORP | Increased | 831,647 | Aug 7, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 823,064 | May 15, 2026 |
| SOLEUS CAPITAL MANAGEMENT, L.P. | Increased | 820,243 | May 14, 2026 |
| STATE STREET CORP | Increased | 771,587 | May 15, 2026 |
| TANG CAPITAL MANAGEMENT LLC | Unchanged | 707,500 | Aug 14, 2026 |
| TANG CAPITAL MANAGEMENT LLC | Increased | 707,500 | May 15, 2026 |
| GOLDENTREE ASSET MANAGEMENT LP | New Position | 667,981 | May 14, 2026 |
| DIMENSIONAL FUND ADVISORS LP | Increased | 623,463 | Aug 11, 2026 |
| DEEP TRACK CAPITAL, LP | Increased | 600,000 | May 15, 2026 |
| MILLENNIUM MANAGEMENT LLC | Increased | 592,013 | May 15, 2026 |
| AMERICAN CENTURY COMPANIES INC | Increased | 574,474 | Aug 12, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Sep 1, 2026